{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:14:18Z","timestamp":1782951258645,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ijrobp.2011.11.038","type":"journal-article","created":{"date-parts":[[2012,2,11]],"date-time":"2012-02-11T05:04:18Z","timestamp":1328936658000},"page":"e701-e707","source":"Crossref","is-referenced-by-count":48,"title":["A New Orally Active, Aminothiol Radioprotector-Free of Nausea and Hypotension Side Effects at Its Highest Radioprotective Doses"],"prefix":"10.1016","volume":"82","author":[{"given":"Cheryl M.","family":"Soref","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Fahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2011.11.038_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/09553000902985144","article-title":"History and development of radiation-protective agents","volume":"85","author":"Weiss","year":"2009","journal-title":"Int J Radiat Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ctrv.2009.12.001","article-title":"Combined treatment with cytoprotective agents and radiotherapy","volume":"36","author":"Winczura","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1667\/RR3388","article-title":"Animal models for radiation injury, protection and therapy","volume":"164","author":"Augustine","year":"2005","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3357\/ASEM.2113.2008","article-title":"Pharmacological agents for the prevention and treatment of toxic radiation exposure in spaceflight","volume":"79","author":"Langell","year":"2008","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2008.17.2627","article-title":"2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants","volume":"27","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib6","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1996.14.7.2101","article-title":"Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: Results of a randomized control trial in patients with advanced ovarian cancer","volume":"14","author":"Kemp","year":"1996","journal-title":"J Clin Oncol"},{"issue":"4 Suppl. 8","key":"10.1016\/j.ijrobp.2011.11.038_bib7","first-page":"83","article-title":"Amifostine cytoprotection with chemotherapy for advanced ovarian carcinoma","volume":"23","author":"Rose","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0360-3016(88)90387-2","article-title":"Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy","volume":"14","author":"Kligerman","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib9","unstructured":"Ethyol package insert. http:\/\/www.ethyol.com\/resources\/pdf\/Ethyol-PI.pdf."},{"key":"10.1016\/j.ijrobp.2011.11.038_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2307\/3575952","article-title":"Determination of the radioprotective effects of topical applications of MEA, WR-2721, and N-acetylcysteine on murine skin","volume":"93","author":"Verhey","year":"1983","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib11","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1002\/1097-0142(19920601)69:11<2826::AID-CNCR2820691131>3.0.CO;2-8","article-title":"Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. A Phase I\/II trial","volume":"69","author":"Montana","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib12","unstructured":"Fahl WE, Peebles DD, Copp RR. Amino thiol compounds and compositions for use in conjunction with cancer therapy. United States patent US 7,314,959."},{"key":"10.1016\/j.ijrobp.2011.11.038_bib13","unstructured":"Peebles DD, Soref CM, Copp RR, et\u00a0al. ROS-Scavenger and Radioprotective Efficacy of the New PrC-210 Aminothiol. Radiat Res. In press."},{"key":"10.1016\/j.ijrobp.2011.11.038_bib14","first-page":"7426","article-title":"Synthesis and growth regulatory activity of a prototype member of a new family of aminothiol radioprotectors","volume":"21","author":"Copp","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib15","unstructured":"Copp RR, Peebles DD, Soref CM, et\u00a0al. Radioprotection conferred by a new family of aminothiol analogs. (submitted)."},{"key":"10.1016\/j.ijrobp.2011.11.038_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuropharm.2009.10.002","article-title":"Olvanil: A non-pungent TRPV1 activator has anti-emetic properties in the ferret","volume":"58","author":"Chu","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib17","series-title":"Radiation offers new cures, and ways to do harm","author":"Bogdanich","year":"2010"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib18","first-page":"1476","article-title":"Predicting the emetic liability of novel chemical entities: A comparative study","author":"du Sert","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijrobp.2011.11.038_bib19","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/CIRCULATIONAHA.107.688101","article-title":"Radiation dose to patients from cardiac diagnostic imaging","volume":"116","author":"Einstein","year":"2007","journal-title":"Circulation"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301611035954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301611035954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T04:52:48Z","timestamp":1543207968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301611035954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0360301611035954"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2011.11.038","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}